1. Home
  2. BMRA vs SHPH Comparison

BMRA vs SHPH Comparison

Compare BMRA & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRA
  • SHPH
  • Stock Information
  • Founded
  • BMRA 1971
  • SHPH 2012
  • Country
  • BMRA United States
  • SHPH United States
  • Employees
  • BMRA N/A
  • SHPH N/A
  • Industry
  • BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • SHPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • BMRA Health Care
  • SHPH Health Care
  • Exchange
  • BMRA Nasdaq
  • SHPH Nasdaq
  • Market Cap
  • BMRA 8.2M
  • SHPH 2.3M
  • IPO Year
  • BMRA N/A
  • SHPH 2022
  • Fundamental
  • Price
  • BMRA $2.93
  • SHPH $4.44
  • Analyst Decision
  • BMRA
  • SHPH
  • Analyst Count
  • BMRA 0
  • SHPH 0
  • Target Price
  • BMRA N/A
  • SHPH N/A
  • AVG Volume (30 Days)
  • BMRA 420.4K
  • SHPH 54.6K
  • Earning Date
  • BMRA 10-14-2025
  • SHPH 11-12-2025
  • Dividend Yield
  • BMRA N/A
  • SHPH N/A
  • EPS Growth
  • BMRA N/A
  • SHPH N/A
  • EPS
  • BMRA N/A
  • SHPH N/A
  • Revenue
  • BMRA $5,311,000.00
  • SHPH N/A
  • Revenue This Year
  • BMRA N/A
  • SHPH N/A
  • Revenue Next Year
  • BMRA N/A
  • SHPH N/A
  • P/E Ratio
  • BMRA N/A
  • SHPH N/A
  • Revenue Growth
  • BMRA N/A
  • SHPH N/A
  • 52 Week Low
  • BMRA $2.08
  • SHPH $3.00
  • 52 Week High
  • BMRA $10.16
  • SHPH $56.25
  • Technical
  • Relative Strength Index (RSI)
  • BMRA 43.81
  • SHPH 71.72
  • Support Level
  • BMRA $2.87
  • SHPH $3.41
  • Resistance Level
  • BMRA $3.08
  • SHPH $4.54
  • Average True Range (ATR)
  • BMRA 0.21
  • SHPH 0.27
  • MACD
  • BMRA 0.01
  • SHPH 0.12
  • Stochastic Oscillator
  • BMRA 57.97
  • SHPH 92.54

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

Share on Social Networks: